1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, October 2016 (p4)

Biological Therapy Analysis & Statistics, October 2016 (p4)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

91-120 of about 1100 reports

Purchase Reports From Reputable Market Research Publishers

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2016

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hematopoietic Stem Cell Transplantation - ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation, Pathology, Biotechnology, Cancer, Healthcare
  • Countries : United States
Epidermolysis Bullosa - Pipeline Review, H2 2016

Epidermolysis Bullosa - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Epidermolysis Bullosa - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epidermolysis Bullosa - Pipeline Review, H2 2016, provides an ...

  • Industries : Pathology
  • Countries : United States
Ageing - Pipeline Review, H2 2016

Ageing - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Ageing - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ageing - Pipeline Review, H2 2016, provides an overview of the Ageing (Metabolic ...

  • Industries : Therapy, Drug Discovery and Development, Biological Therapy, Pharmaceutical
  • Countries : World
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsing Remitting Multiple Sclerosis ...

  • Industries : Pathology, Mental Health, Therapy
  • Countries : United States, Europe, World
Hepatitis C - Pipeline Review, H2 2016

Hepatitis C - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Hepatitis C - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C - Pipeline Review, H2 2016, provides an overview of the Hepatitis ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2016

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leber Congenital Amaurosis (LCA) - Pipeline Review, ...

  • Industries : Therapy
  • Countries : United States
Hemophilia B - Pipeline Review, H2 2016

Hemophilia B - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Hemophilia B - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hemophilia B - Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Pathology
  • Countries : United States, World, Europe
Neutropenia - Pipeline Review, H2 2016

Neutropenia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Neutropenia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Neutropenia - Pipeline Review, H2 2016’, provides an overview of the Neutropenia pipeline landscape. The report provides comprehensive ...

  • Industries : Pharmaceutical, Biopharmaceutical, Therapy, Biotechnology, Biological Therapy
  • Countries : United States
Hypersensitivity - Pipeline Review, H2 2016

Hypersensitivity - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Hypersensitivity - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hypersensitivity - Pipeline Review, H2 2016’, provides an overview of the Hypersensitivity pipeline landscape. The report ...

  • Industries : Therapy, Pharmaceutical, Biopharmaceutical, Biotechnology, Pathology
  • Countries : United States, World
Metastatic Melanoma - Pipeline Review, H2 2016

Metastatic Melanoma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Metastatic Melanoma - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H2 2016’, provides an overview of the Metastatic Melanoma pipeline landscape. ...

  • Industries : Cancer, Pathology
  • Countries : United States
Myocardial Infarction - Pipeline Review, H2 2016

Myocardial Infarction - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Myocardial Infarction - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H2 2016’, provides an overview of the Myocardial Infarction pipeline landscape. ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Friedreich Ataxia - Pipeline Review, H2 2016

Friedreich Ataxia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Friedreich Ataxia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Friedreich Ataxia - Pipeline Review, H2 2016’, provides an overview of the Friedreich Ataxia pipeline landscape. The ...

  • Industries : Therapy, Pathology, Pharmaceutical, Mental Health
  • Countries : United States
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016’, provides an overview ...

  • Industries : Cancer, Pathology, Therapy, Biopharmaceutical
  • Countries : United States
Allergic Rhinitis - Pipeline Review, H2 2016

Allergic Rhinitis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Allergic Rhinitis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Allergic Rhinitis - Pipeline Review, H2 2016’, provides an overview of the Allergic Rhinitis pipeline landscape. The ...

  • Industries : Chronic Disease, Pathology
  • Countries : Japan, World, United States
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016’, provides an overview of the Graft Versus ...

  • Industries : Blood Supply, Tissue Banking and Transplantation, Healthcare
  • Countries : United States
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2016

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : United States
Liver Fibrosis - Pipeline Review, H2 2016

Liver Fibrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Liver Fibrosis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Liver Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Liver Fibrosis pipeline landscape. The report provides ...

  • Industries : Pathology, Therapy, Pharmaceutical, Biotechnology
  • Countries : United States
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline ...

  • Industries : Cancer, Pathology
  • Countries : United States
Myelodysplastic Syndrome - Pipeline Review, H2 2016

Myelodysplastic Syndrome - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Myelodysplastic Syndrome - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides ...

  • Industries : Cancer, Pathology
  • Countries : United States
Stroke - Pipeline Review, H2 2016

Stroke - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Stroke - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke – Pipeline Review, H2 2016, provides an overview of the Stroke (Cardiovascular) ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States
Aplastic Anemia - Pipeline Review, H2 2016

Aplastic Anemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Aplastic Anemia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Pathology
  • Countries : United States
Neuroblastoma - Pipeline Review, H2 2016

Neuroblastoma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Neuroblastoma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroblastoma – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Cancer, Pathology
  • Countries : United States
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia ...

  • Industries : Cancer, Pathology
  • Countries : United States
Osteonecrosis - Pipeline Review, H2 2016

Osteonecrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Osteonecrosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteonecrosis – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Therapy
  • Countries : United Kingdom, World
Spinal Cord Injury - Pipeline Review, H2 2016

Spinal Cord Injury - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Spinal Cord Injury - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Cord Injury – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Chronic Lymphocytic Leukemia ...

  • Industries : Cancer, Pathology
  • Countries : United States
Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus (HHV-5) Infections – Pipeline ...

  • Industries : Therapy, Biotechnology, Pathology, Biopharmaceutical, Biological Therapy, Pharmaceutical
  • Countries : United States
Critical Limb Ischemia - Pipeline Review, H2 2016

Critical Limb Ischemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Critical Limb Ischemia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Critical Limb Ischemia – Pipeline Review, H2 2016, provides ...

  • Industries : Biological Therapy, Chronic Disease, Pathology, Therapy
  • Countries : United States
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia ...

  • Industries : Cancer, Pathology
  • Countries : United States
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes (Juvenile Diabetes) – Pipeline ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.